Carisma Therapeutics Inc
NASDAQ:CARM 11:25:17 AM EDT
| Market Cap (Intraday) | 41.96M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.02 |
| 50-Day MA | $1.07 |
| 200-Day MA | $1.79 |
Carisma Therapeutics Inc Stock, NASDAQ:CARM
3675 Market Street, Suite 200, Philadelphia, Pennsylvania 19104
United States of America
Phone: +1.617.444.8550
Number of Employees: 107
Description
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.